Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gyarfas

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Servir (Lisbon, Portugal)|July 1, 1992
[Cardiovascular diseases: the No. 1 enemy of public health in the whole world]I Gyarfas
Journal of Cardiovascular Pharmacology|January 1, 1990
Lifestyle for preventing cardiovascular diseaseI Gyarfas
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1992
Review of community intervention studies on cardiovascular risk factorsI Gyarfas
Hygie|January 1, 1992
The WHO Cardiovascular Health ProgrammeI Gyarfas
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 1996
Control of hypertension in the population. Strategies in affluent and developing countriesI Gyarfas
Journal of Human Hypertension|February 1, 1996
Lessons from worldwide experience with hypertension controlI Gyarfas
Health Promotion (Oxford, England)|April 10, 1986
The role of health promotion in prevention policy against cardiovascular diseases in HungaryM Kokeny, I Gyarfas, P Makara, et al.
Przeglad Lekarski|January 1, 1989
[Up-to-date results and concepts of further studies toward improving the effectiveness of detecting arterial hypertension and the ambulatory care of patients with hypertension]E Benko, J Duba, I Gyarfas, et al.
Sports Medicine (Auckland, N.Z.)|March 1, 1996
Development of public policy and physical activity initiatives internationallyS N Blair, M Booth, I Gyarfas, et al.
Casopis Lekaru Ceskych|April 13, 1979
[Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study]H Geizerová, I Gyarfas, G Lamm, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Servir (Lisbon, Portugal)|July 1, 1992
[Cardiovascular diseases: the No. 1 enemy of public health in the whole world]I Gyarfas
Journal of Cardiovascular Pharmacology|January 1, 1990
Lifestyle for preventing cardiovascular diseaseI Gyarfas
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1992
Review of community intervention studies on cardiovascular risk factorsI Gyarfas
Hygie|January 1, 1992
The WHO Cardiovascular Health ProgrammeI Gyarfas
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 1996
Control of hypertension in the population. Strategies in affluent and developing countriesI Gyarfas
Journal of Human Hypertension|February 1, 1996
Lessons from worldwide experience with hypertension controlI Gyarfas
Health Promotion (Oxford, England)|April 10, 1986
The role of health promotion in prevention policy against cardiovascular diseases in HungaryM Kokeny, I Gyarfas, P Makara, et al.
Przeglad Lekarski|January 1, 1989
[Up-to-date results and concepts of further studies toward improving the effectiveness of detecting arterial hypertension and the ambulatory care of patients with hypertension]E Benko, J Duba, I Gyarfas, et al.
Sports Medicine (Auckland, N.Z.)|March 1, 1996
Development of public policy and physical activity initiatives internationallyS N Blair, M Booth, I Gyarfas, et al.
Casopis Lekaru Ceskych|April 13, 1979
[Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study]H Geizerová, I Gyarfas, G Lamm, et al.
Pageof 2